Generation Bio Co.
GBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $70,622 | $106,398 | $228,392 | $398,571 |
| - Cash | $76,301 | $66,446 | $93,171 | $375,145 |
| + Debt | $93,560 | $97,894 | $81,707 | $80,825 |
| Enterprise Value | $87,881 | $137,846 | $216,928 | $104,251 |
| Revenue | $19,892 | $5,904 | $0 | $0 |
| % Growth | 236.9% | – | – | – |
| Gross Profit | $19,892 | $5,904 | $0 | $0 |
| % Margin | 100% | 100% | – | – |
| EBITDA | -$74,262 | -$133,300 | -$136,052 | -$114,569 |
| % Margin | -373.3% | -2,257.8% | – | – |
| Net Income | -$131,668 | -$126,612 | -$136,639 | -$119,151 |
| % Margin | -661.9% | -2,144.5% | – | – |
| EPS Diluted | -19.76 | -19.63 | -23.51 | -21.17 |
| % Growth | -0.7% | 16.5% | -11.1% | – |
| Operating Cash Flow | -$88,563 | -$52,745 | -$102,448 | -$91,821 |
| Capital Expenditures | -$2,401 | -$7,397 | -$8,801 | -$5,958 |
| Free Cash Flow | -$90,964 | -$60,142 | -$111,249 | -$97,779 |